Director Homaira Akbari discloses 50,000 BW shares in Form 3 filing

Rhea-AI Filing Summary

Babcock & Wilcox Enterprises director Dr. Homaira Akbari reports ownership of 50,000 shares of the company's common stock. The shares are reported as held directly, reflecting her initial beneficial ownership position as of January 26, 2026 under insider reporting rules.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Akbari Dr. Homaira

(Last) (First) (Middle)

1200 E. MARKET STREET, SUITE 650

(Street)

AKRON OH 44305

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/26/2026

3. Issuer Name and Ticker or Trading Symbol
Babcock & Wilcox Enterprises, Inc. [ BW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	50,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ John J. Dziewisz, attorney-in-fact for Homaira Akbari	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Babcock & Wilcox (BW) insider Dr. Homaira Akbari report on this Form 3?

Dr. Homaira Akbari reports beneficial ownership of 50,000 shares of Babcock & Wilcox common stock. This Form 3 filing discloses her initial holdings as a director, giving investors transparency into her direct equity stake in the company.

How many Babcock & Wilcox (BW) shares does director Homaira Akbari own?

The filing shows Dr. Akbari beneficially owns 50,000 shares of Babcock & Wilcox common stock. These shares are held directly, meaning they are not reported through any trust, partnership, or other indirect ownership structure in this disclosure.

Is the ownership reported by Homaira Akbari in BW stock direct or indirect?

The Form 3 indicates Dr. Akbari's 50,000 BW shares are held directly, marked with the code "D". No nature of indirect beneficial ownership is listed, suggesting no intermediary entity is involved for this reported position.

What is the event date for Homaira Akbari’s Babcock & Wilcox (BW) Form 3?

The event date for this Form 3 is January 26, 2026. That date anchors when Dr. Akbari's initial beneficial ownership in 50,000 BW common shares became reportable under Section 16 insider reporting requirements.

What is Homaira Akbari’s relationship to Babcock & Wilcox (BW) in this filing?

Dr. Homaira Akbari is identified as a director of Babcock & Wilcox Enterprises. The Form 3 reflects her status as an insider and discloses her 50,000-share direct ownership position in the company’s common stock.